BCL9L Antibody
B-cell lymphoma 9-like protein (BCL9L) is a transcriptional regulator that acts as an activator. BCL9L promotes beta-catenin transcriptional activity and plays a role in tumorigenesis [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/ Q86UU0].
Alternative names for BCL9L Antibody include B-cell CLL/lymphoma 9-like antibody, BCL9-2 antibody, DLNB11 antibody.
| Product/Catalog # | Specifications | Price |
|---|---|---|
| BCL9L Antibody A303-152A | Reactivity:
Human Applications: WB, IP |
$314.00 Bulk Quote Data Sheet Add to Cart |
Quick Order
Pathways
Featured Collections
- Actin Cytoskeleton
- ATM-ATR Signaling
- COMT and Schizophrenia
- Condensin Complex
- ErbB2 Pathway in Breast Cancer
- GTPase Regulation
- Homologous Recombination
- Inflammation and Cancer
- IRF8 Implications in Disease & Development
- Jumonji and Cancer
- MAPs
- Methylation and Memory Formation
- Mitosis and Cell Cycle Progression
- mTOR
- Mutant EGFR analysis by PLA
- NF-kappa B
- Nucleoporin
- Novel Cancer Biomarkers
- Stat Signaling and Cancer
- SWI/SNF-like
- Translation Initiation
- USP
- WD-repeat
- Wnt Signaling
- XP
Every Bethyl product ships with a 100% guarantee; choose Bethyl antibodies with confidence.
